Lexaria BioscienceLEXX
13F holders, Q3 2024 (September 30)27holders −1
6new positions
7sold out
$3.05avg. 13F price*
At the end of Q3 2024, 27 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings, down 1 from Q2 2024. 6 opened new positions and 7 sold out. The largest holders were Invenomic Capital Management LP ($1.5M), Geode Capital Management, LLC ($459K) and Vanguard Group Inc. ($333K).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $130K |
| Exits | 7 | $2.9M |
All 13F filers, Q2 2024 → Q3 2024: 99,998 shares bought and 1,091,159 shares sold, net −991,161 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Invenomic Capital Management LP | 0.08% | Reduce -7.4% | 475,773 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Add +31.0% | 150,391 | $459K |
| Vanguard Group Inc. | 0.00% | Add +16.5% | 109,022 | $333K |
| GenTrust, LLC | 0.01% | No change | 60,000 | $183K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | Reduce -8.0% | 44,900 | $137K |
| State Street Corp. | 0.00% | No change | 39,301 | $120K |
| BlackRock, Inc. | 0.00% | — | 27,445 | $84K |
| Welch Group, LLC | 0.00% | No change | 24,000 | $73K |
| Morgan Stanley | 0.00% | No change | 22,982 | $70K |
| XTX Topco Ltd | 0.00% | Add +47.8% | 18,626 | $57K |
| Northern Trust Corp. | 0.00% | No change | 18,389 | $56K |
| Bank of Montreal | 0.00% | New | 14,000 | $42K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 13,823 | $42K |
| HighTower Advisors, LLC | 0.00% | New | 13,023 | $40K |
| HRT Financial LP | 0.00% | New | 10,257 | $31K |
| Royal Bank of Canada | 0.00% | No change | 7,283 | $22K |
| Byrne Asset Management LLC | 0.01% | New | 5,600 | $17K |
| Oakworth Capital, Inc. | 0.00% | No change | 5,000 | $15K |
| Wells Fargo & Company | 0.00% | Reduce -24.2% | 2,500 | $8K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,290 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -60.1% | 1,344 | $4K |
| Aspire Private Capital, LLC | 0.00% | No change | 400 | $1K |
| Farther Finance Advisors, LLC | 0.00% | No change | 166 | $506 |
| Bank of America Corp. | 0.00% | Add +19.8% | 115 | $351 |
| Sound Income Strategies, LLC | 0.00% | New | 22 | $68 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $40 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 9 | $27 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.